ABT Competitors
Abbott Laboratories
$102.97
+$0.36(+0.35%)
54
Overall
90
Value
27
Tech
47
Quality
Market Cap
$178.18B
Volume
7.27M
52W Range
$81.97 - $133.34
Target Price
$120.74
ABT competitors: JNJ, PFE, MDT, TMO, BMY. Abbott Laboratories is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
ABT Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| JNJ Johnson & Johnson | $253.91 | $599.12B | $11.09 | 2.08% | 56 |
| PFE Pfizer Inc. | $29.21 | $166.49B | $2.96 | 5.89% | 70 |
| MDT Medtronic plc | $94.23 | $120.53B | $5.98 | 3.04% | 73 |
| TMO Thermo Fisher Scientific Inc. | $673.20 | $248.91B | $25.13 | 0.27% | 67 |
| BMY Bristol-Myers Squibb Company | $59.28 | $121.09B | $6.80 | 3.19% | 63 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABT | $102.97 | +0.4% | 7.27M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |